Concepedia

Author

Manal Abunimeh

AbbVie (United States)

Also Known As

M. Abunimeh, Manal Abunimeh

18

Publications

480

Citations

7

H-Index

9

Concepts

All Affiliations

AbbVie (United States)The University of Texas Health Science Center at San AntonioTexas Liver InstituteScripps ClinicJohns Hopkins University
MA

About

Manal Abunimeh is an author at AbbVie (United States) specializing in viral hepatitis, virology, and hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

101

2

Viral Hepatitis

2

2

101

3

Epidemiology

1

1

27

4

Nephrology

1

1

74

5

Chronic Kidney Disease

1

1

74

Manal Abunimeh

×

5

Publications

454

Citations

5

H-Index

YearCitations

Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease

Paul J. Pockros, K. Rajender Reddy, Parvez Mantry,

Gastroenterology

2016

277

LO1 : Safety of ombitasvir/paritaprevir/ritonavir plus dasabuvir for treating HCV GT1 infection in patients with severe renal impairment or end-stage renal disease: The RUBY-I study

Paul J. Pockros, K. Rajender Reddy, Parvez Mantry,

Journal of Hepatology

2015

74

Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection

Eric Lawitz, Robert Flisiak, Manal Abunimeh,

Liver International

2019

62

Ombitasvir/Paritaprevir/R, Dasabuvir, and Sofosbuvir Treatment of Patients with HCV Genotype-Infection who Failed a Prior Course of DAA Therapy: The Quartz-I Study

F. Poordad, Michael Bennett, Thomas Sepe,

Journal of Hepatology

2016

27

Efficacy and safety results of patients with <scp>HCV</scp> genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (<scp>QUARTZ II</scp>‐<scp>III</scp>)

Stephen D. Shafran, Douglas W. Shaw, Mariem Charafeddine,

Journal of Viral Hepatitis

2017

14

Page 1